PharmaFoods International operates across three core segments: BtoB (business-to-business supply of proprietary functional ingredients such as PharmaGABA, BonePep, and HGP to food and pharmaceutical manufacturers), BtoC (direct-to-consumer e-commerce sales of supplements, quasi-drugs, and cosmetics including the flagship 'Newmo' hair growth treatment), and Biomedical (R&D of antibody and peptide therapeutics targeting autoimmune diseases, cancer, and rare diseases, utilizing its proprietary ALAgene technology platform, with a licensing-out commercialization model). The group also includes contract pharmaceutical manufacturing (CMO) and consumer healthcare (CHC) operations through consolidated subsidiary Meiji Pharmaceutical Co., Ltd.
Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.
Free Demo (No Time Limit, 10 Companies) →PharmaFoods International operates across three core segments: BtoB (business-to-business supply of proprietary functional ingredients such as PharmaGABA, BonePep, and HGP to food and pharmaceutical manufacturers), BtoC (direct-to-consumer e-commerce sales of supplements, quasi-drugs, and cosmetics including the flagship 'Newmo' hair growth treatment), and Biomedical (R&D of antibody and peptide therapeutics targeting autoimmune diseases, cancer, and rare diseases, utilizing its proprietary ALAgene technology platform, with a licensing-out commercialization model). The group also includes contract pharmaceutical manufacturing (CMO) and consumer healthcare (CHC) operations through consolidated subsidiary Meiji Pharmaceutical Co., Ltd.
Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.
Free Demo (No Time Limit, 10 Companies) →